<unk>  is contraindicated in: * Patients with severe renal impairment, including those receiving dialysis (2.7-fold increase in exposure, and increased accumulation during chronic dosing in patients with estimated glomerular filtration rate < 30 mL/min) * Patients with active liver disease, including those with primary biliary cirrhosis and unexplained persistent liver function test abnormalities * Patients with preexisting gallbladder disease * Nursing mothers * Hypothyreosis * Patients with known hypersensitivity to<unk>  or<unk> fibric acid
Fenofibrate
Clofibrate
Ezetimibe
Lovastatin
Atorvastatin
Simvastatin
Gemfibrozil
Fluvastatin